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ABSTRACT
Objective: Little is known about the prevalence of neuropsychiatric symptoms (NPS) and psychotropic
drug use (PDU) in patients below the age of 65 years with acquired brain injury (ABI) in long-term care.
The objective of this study was to review the literature about the prevalence of NPS and PDU.
Methods: A systematic literature search of English, Dutch and German articles in Pubmed, EMBASE,
PsycINFO and CINAHL was performed with the use of MeSH and free-text terms.
Results: Six articles met the inclusion criteria. The place of residence was mainly a nursing home and
most studies were conducted in a population of patients with traumatic brain injury. Sample sizes varied
from 40 to 26,472 residents and NPS were assessed with different assessment instruments. Depressive
symptoms were most common with a prevalence ranging from 13.9% to 39.3%. Two studies reported
PDU in which tranquillizers (59%) were the most prevalent psychotropic drugs followed by antic-
onvulsants (35%) and antidepressants (26–34%).
Conclusions: Patients with ABI experience lifelong consequences, regardless the cause of ABI, that have
a high impact on them and their surroundings. More insight into the magnitude of NPS and PDU,
through prevalence studies, is necessary to achieve suitable provision of care for these patients.
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Introduction
Acquired brain injury (ABI) is an injury to the brain that is not
hereditary, congenital, degenerative or induced by a birth trauma,
but the result of a sudden event whereby the damage can be focal
or diffuse (1). ABI can be traumatic or non-traumatic. The sever-
ity can range from amild temporary concussion to severe damage
resulting in a permanent vegetative state, renamed as unrespon-
sive wakefulness syndrome (VS/UWS), or death (1,2).
Brain injury is a major cause of death and disability (3). The
mean European incidence of hospitalized and fatal traumatic
brain injury (TBI) is about 235 per 100,000 but prevalence data
were not reported from any European country (4). Globally, TBI
affects approximately 10 million people (5). The most injuries
occur in the very young (0–4 years), adolescents (15–24 years),
and in people over 65 years of age (6). In a study in the
Netherlands (n = 1892), accidents appeared to be the most
common cause of TBI as were hypoxic–ischemic events for
NTBI in youth aged 1 month to 24 years (7). More than 15%
of TBI and NTBI were classified as moderate or severe.
Brain injury can have a direct effect on behavioural control
due to injury of frontal, temporal and sub-cortical areas of the
brain (8,9). A patient’s behaviour may also be the result of
frustration with the limitations caused by disability, which put
a high burden on the patient and his/her environment (9,10).
Behavioural problems occurring after brain injury were
reported in a follow-up study of patients with a mean age of
30.4 years during hospital stay (n = 16) and after discharge to
home (n = 33) (9). The highest prevalence rates of apathy,
irritability, and aggression were found at home, with 73%,
78%, and 55.5%, respectively. In the hospital, the prevalence
rates were 25%, 31%, and 6%, respectively.
Patients in the chronic phase of ABI who are unable to live
at home are commonly admitted to a long-term care facility
(LTCF). Long-term care refers to health, social and residential
services provided to chronically disabled persons over an
extended period of time (11). ABI was the most common
cause of disability in 122 patients and challenging behaviour
was found in 207 patients in the general population of people
below 60 years of age in an Australian study in residential
aged care (n = 330) (12). However, from this study it is not
clear how many patients with ABI had challenging behaviour.
Little is known about the population of people up to
65 years of age with ABI that resides in LTCFs. The avail-
ability of data about characteristics, neuropsychiatric symp-
toms (NPS) and psychotropic drug use (PDU) in this group of
patients remains unclear. These patients experience lifelong
consequences, regardless the cause of ABI that has a high
impact on them and their surroundings. Insight into the
magnitude of NPS and PDU is necessary to achieve suitable
care for these patients. Thereto, the specific question to be
answered is: What are the prevalence rates of NPS and PDU
for NPS among patients below 65 years of age with ABI in
long-term care? Therefore, the aim of this study was to sys-
tematically review the literature about the prevalence and
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characteristics of NPS and PDU in patients below 65 years of
age with ABI in long-term care.
Methods
Search strategy
The approach used for this systematic review was the
Preferred Reporting Items for Systematic reviews and
Meta-Analyses (PRISMA) (13). The databases Pubmed,
EMBASE, PsycINFO (both via Ovid), and CINAHL were
searched.
Through the supervision of a librarian from the Radboud
University, a list of Medical Subject Headings (MeSH) and
free text words, indicating the setting, the wide range of
causes of ABI and NPS, and PDU, was used to retrieve
relevant articles from Pubmed (Table 1) and was translated
for use in EMBASE, PsycINFO and CINAHL. We used an
extensive amount of search terms to find as many relevant
papers as possible. The Neuropsychiatric Inventory Nursing
Home version (NPI-NH) was used as template for the NPS
(14). The NPI, a structured interview including 12 NPS, is
suitable for assessing NPS in ABI and has been used in severe
and moderate TBI (15,16). With regard to PDU, the
Anatomical Chemical Classification of the World Health
Organization was used as template (17). The search was
performed using the following limits: Humans, Adult (19
+ years), Adult (19–44 years), Middle Aged (45–64 years),
English, Dutch and German. There were no limits concerning
the year of publication. The search was performed by two
researchers (RFK and DLG) independently and took place in
May 2016. The resulting articles were combined in Endnote
and duplicates were removed.
Inclusion criteria
Inclusion criteria were (1) patients with a mean/median age
below 65 years, and (2) in the chronic phase of nonprogres-
sive ABI. The nonprogressive forms of ABI can be traumatic,
haemorrhagic and ischemic stroke, stable situation after brain
tumour with residual damage treated with surgery and/or
radiotherapy, hypoxia/anoxia, cerebral infections, intoxica-
tions and metabolic disorders (1,18).
We chose the age of 65 years as a limit because it was until
recently the retirement age in the Netherlands and with this
the upper limit for (the possibility of) employment. Instead of
using an inclusion criterion regarding a maximum age, the
mean/median age was used to include as many relevant stu-
dies as possible.
Exclusion criteria
Exclusion criteria were (1) studies in patients with a mean/
median age ≥65 years, (2) patients living in the community,
(3) patients with disorders of consciousness (DOC) (4)
patients in the acute phase (hospital) and rehabilitation
phase (rehabilitation centre) of ABI, (5) degenerative forms
of ABI, and (6) Korsakoff’s Syndrome. The degenerative
forms can be dementia, multiple sclerosis, Parkinson’s disease,
Huntington’s disease, progressive supranuclear palsy, mito-
chondrial disease, cerebellar ataxia, multisystem atrophy,
Table 1. Used search terms in Pubmed.
Setting:
(“Long Term Care”[MeSH] OR “Long Term Care”[All Fields] OR “Nursing Homes”[MeSH] OR Nursing Home*[All Fields] OR “Skilled Nursing Facilities”[MeSH] OR
Skilled Nursing Facilit*[All Fields])
Causes:
(“Brain Abscess”[MeSH] OR Brain Abscess*[All Fields] OR “Brain Anoxia”[All Fields] OR Brain Hemorrhage*[All Fields] OR “Brain Infarction”[MeSH] OR Brain
Infarction*[All Fields] OR Brain Inflammation*[All Fields] OR “Brain Injury, Chronic”[MeSH] OR “Brain Injuries”[MeSH] OR Brain Injur*[All Fields] OR “Brain Stem
Hemorrhage, Traumatic”[MeSH] or Brain Stem Hemorrhage*[All Fields] OR Brainstem Hemorrhage*[All Fields] OR “Brain Stem Infarctions”[MeSH] OR Brain Stem
Infarction*[All Fields] OR Cerebral Abscess*[All Fields] OR “Cerebral Anoxia”[All Fields] OR “Cerebral Hemorrhage”[MeSH] OR “Cerebral Hemorrhage,
Traumatic”[MeSH] OR Cerebral Hemorrhage*[All Fields] OR “Cerebrovascular Trauma”[MeSH] OR “Encephalitis”[MeSH] OR Encephalitis[All Fields] OR
Encephalopath*[All Fields] OR “Head Injuries, Penetrating”[MeSH] OR Head Injur*[All Fields] OR “Hypoxia, Brain”[MeSH] OR “Intracranial Hemorrhage,
Hypertensive”[MeSH] OR “Leukoencephalitis, Acute Hemorrhagic”[MeSH] OR Locked In Syndrome[All Fields] OR Locked-in Syndrome[All Fields] OR
“Meningioma”[MeSH] OR Meningioma*[All Fields] OR “Meningitis”[MeSH] OR Meningitis[All Fields] OR “Quadriplegia”[MeSH] OR Quadriplegia[All Fields] OR
“Stroke”[MeSH] OR Stroke*[All Fields] OR “Subarachnoid Hemorrhage”[MeSH] OR Subarachnoid Hemorrhage*[All Fields] OR TBI[All Fields])
Neuropsychiatric Symptoms:
(“Affect”[MeSH] OR Affect[All Fields] OR “Aggression”[MeSH] OR Aggression[All Fields] OR Agitation[All Fields] OR “Anxiety”[MeSH] OR Anxiety[All Fields] OR
“Apathy”[MeSH] OR Apathy[All Fields] OR “Appetite”[MeSH] OR Appetite[All Fields] OR “Behavioral Symptoms”[MeSH] OR Behavioral Symptom*[All Fields] OR
Behavioural Symptom*[All Fields] OR “Cooperative Behavior”[MeSH] OR Cooperative Behavior*[All Fields] OR Cooperative Behaviour*[All Fields] OR
“Delusions”[MeSH] OR Delusion*[All Fields] OR “Depression”[MeSH] OR Depression[All Fields] OR “Depressive Disorder”[MeSH] OR Depressive Disorder*[All Fields]
OR Disinhibition[All Fields] OR Eating Disorder*[All Fields] OR “Euphoria”[MeSH] OR Euphoria[All Fields] OR “Feeding and Eating Disorders”[MeSH] OR
“Hallucinations”[MeSH] OR Hallucination*[All Fields] OR “Hearing Loss”[MeSH] OR Hearing[All Fields] OR “Irritable Mood”[MeSH] OR Irritable Mood[All Fields] OR
Irritability[All Fields] OR “Mental Health”[MeSH] OR Mental[All Fields] OR “Mood Disorders”[MeSH] OR Mood Disorder*[All Fields] “Neurobehavioral
Manifestations”[MeSH] OR Neurobehavioral Manifestation*[All Fields] OR Neurobehavioural Manifestation*[All Fields] OR “Neuropsychiatry”[MeSH] OR
Neuropsychiatry[All Fields] OR Neuropsychiatric[All Fields] OR “Neuropsychology”[MeSH] OR Neuropsychology[All Fields] OR “Personality”[MeSH] OR Personality
[All Fields] OR “Psychomotor Agitation”[MesH] OR Psychosis[All Fields] OR “Psychotic Disorders”[MeSH] OR Psychotic Disorder*[All Fields] OR “Sexual
Behavior”[MeSH] OR Sexual Behavior*[All Fields] OR Sexual Behaviour*[All Fields] OR Sleep Behavior Disorder*[All Fields] OR Sleep Behaviour Disorder*[All Fields]
OR “Sleep Wake Disorders”[MeSH] OR Sleep Disorder*[All Fields] OR “Social Behavior Disorders”[MeSH] OR Social behavior Disorder*[All Fields] OR Social
Behaviour Disorder*[All Fields] OR “Somnambulism”[MeSH] OR Vision[All Fields] OR “Vision Disorders”[MeSH] OR “Wandering Behavior”[MeSH] OR Wandering
Behavior*[All Fields] OR Wandering Behaviour*[All Fields] OR Nocturnal Wandering[All Fields])
Psychotropic Drugs:
(“Antidepressive Agents”[MeSH] OR Antidepressive[All Fields] OR “Antipsychotic Agents”[MeSH] OR Antipsychotic[All Fields] OR “Drug Prescriptions”[MeSH] OR
“Hallucinogens”[MeSH] OR Hallucinogen*[All Fields] OR Pharmacologic*[All Fields] OR Pill*[All Fields] OR Prescribing[All Fields] OR Prescription*[All Fields] OR
“Psychotropic Drugs”[MeSH] OR Psychotropic[All Fields] OR “Tranquilizing Agents”[MeSH] OR Tranquilizing[All Fields] OR Tranquilizer*[All Fields] OR Hypnotic*
[All Fields] OR Sedative*[All Fields])
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stroke in progressive or degenerative disorder, and brain
tumour with progressive deterioration (18).
Eligibility assessment
Original research papers and reviews were considered. Two
authors (RFK and DLG) independently screened titles and
abstracts on their potential to meet the inclusion criteria. The
two reviewers compared the list of selected abstracts and in case
of disagreement or when there was insufficient information in
the abstract to evaluate the inclusion and exclusion criteria, the
full text paper was studied by both reviewers. Disagreements
were discussed until consensus was reached.
Data extraction
From the final set of included full text papers, information
was extracted on country, year of publication, study design,
setting, sample size, mean/median age of patients, methods to
assess NPS and PDU, and the prevalence of NPS and PDU
using a predefined data extraction form.
Quality assessment
Two authors (RFK and OMS) evaluated the methodological
quality of the selected studies independently. Studied were the
sample size, what instruments were used to assess NPS and PDU,
response rates when questionnaires were used, the construction
of estimates, and how the diagnosis was made and by whom.
Also, the methodological quality of the included articles was
rated in a structured manner with eight criteria from Boyle’s
Guidelines for evaluating prevalence studies and adapted by
Pitfield et al. (19,20). These criteria represent guidelines to eval-
uate the basic elements of prevalence studies: sampling, measure-
ment and analysis (20). The objective is to help make informed
judgements about the validity of prevalence studies. Boyle’s
criteria are found in Table 2. Pitfield adapted the Guidelines by
adding a rating to these criteria in which a criterion was rated
with zero points if the criterion was not met, 0.5 points if it was
partially met and 1 point if it was completely met (19).
Each paper was rated using an electronic form with the eight
criteria and a total score was calculated. A total score below 3
was considered as poor, 3–6 as moderate, and greater than or
equal to 6 as good methodological quality. This grouping was
based upon the methodological evaluation of included studies in
the systematic review of Van den Brink et al. which used these
guidelines for evaluating prevalence studies (27). The individual
scores of the raters (RFK and OMS) on the criteria and the total
scores of each study were compared and disagreements were
discussed until consensus was reached.
Results
Search strategy
The literature search revealed 931 references. A total of 103
duplicates were removed. The remaining 828 references were
screened on title and abstract. A total of 750 references were
excluded. From 78 records, the full text article was retrieved
for assessing eligibility. Six articles appeared to meet the
inclusion criteria (Figure 1).
Design and study population
Most studies had a cross-sectional design. The place of resi-
dence was mainly a nursing home. Four studies were conducted
in the USA and the other two studies were conducted in
Scotland and Germany, respectively. The four studies con-
ducted in the USA used the Minimum Data Set (MDS) which
included all residents in all Medicare and Medicaid-certified
nursing facilities (28). The MDS records behavioural concerns
and medications (21,25). Behavioural concerns were items
reflecting verbally abusive, physically abusive and socially inap-
propriate behaviours (24). All behavioural symptoms are rated
on two criteria and one of these criteria was the symptom
frequency in the last 7 days with four possible ratings ranging
from not ‘exhibited’ to ‘daily’ (25). Two of the studies obtained
data from nursing home patients with TBI throughout the USA
(21,24). One study used MDS data of patients with TBI from
215 Medicare- and Medicaid-certified nursing homes in
Table 2. Methodological evaluation of the studies (Boyle, 1998).
Buchanan
et al., 2003 (21)
McMillan et al.,
2004 (22)
Gabella et al.,
2007 (23)
Karon et al.,
2007 (24)
Belanger et al.,
2008 (25)
Wolf-Ostermann
et al., 2004 (26)
1. Was the target population defined clearly? 1 1 1 1 1 1
2. Was probability sampling used to identify
potential respondents, or the whole
population approached?
1 1 1 1 1 1
3. Did characteristics of respondents match
the target population?
1 1 1 1 1 1
4. Were the data collection methods
standardized?
1 1 1 1 1 1
5. Were the survey instruments reliable? ? 0.5 ? 0.5 0.5 1
6. Were the survey instruments valid? 0.5 0.5 0.5 0.5 0.5 0.5
7. Were special features of the sampling
design accounted for in the analysis,
through appropriate weighting of the
data, or the whole population
approached?
1 1 1 1 1 1
8. Do the reports include confidence
intervals for statistical estimates or was
the whole population approached?
1 1 1 1 1 1
Quality Score 6.5 7 6.5 7 7 7.5
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Colorado (23). The last study conducted a retrospective review
of the MDS in which data were obtained nationally from the
Veterans Health Administration which operates nursing homes
at 134 medical centres across the USA and Puerto Rico (25).
In the Scottish study, a survey was conducted to describe
the characteristics, level of disability and services received by
patients with ABI between 16 and 64 years old residing in
nursing homes in Greater Glasgow (22). This study used self-
developed questionnaires (Form A and B) and the medication
cardex, a medication administration record, was reviewed.
Form A was used among patients admitted to the nursing
home after a brain injury survey in February 1999. Form B
was a shorter questionnaire and was sent to nursing homes
where patients with brain injury had been identified in the
survey of February 1999. One of the items in Form A
regarded current and past history of behavioural problems.
In the German study, patients with ABI moved from a
residential living facility to two supported living accommoda-
tions (SLA) and its aim was to compare the changes of
residents’ social and health-related outcomes in the SLA
group with the group who remained in stationary care (26).
The study measured anxiety and depression, which were
assessed with the Hospital Anxiety Depression Scale (HADS).
The sample size of the studies varied widely from 40 to
26 472 patients. The mean/median age ranged from 46.2 to
64.6 years. In four studies, two-thirds of the patients were
men (21,23,24,26). In one study, only men were included
(25). Female residents constituted fewer than 2% of the
cases and were excluded. Four studies were performed in
a population solely existing of patients with TBI (21,23–25).
The other two studies were conducted in a population with
different causes of ABI and each reported a group ‘other
brain injury’ without mentioning the types of ABI (22,26).
The characteristics of the studies and the types of ABI are
displayed in Table 3.
Neuropsychiatric symptoms
The prevalence of depression (four studies) ranged from
13.9% to 39.3%, anxiety (three studies) from 2.8% to 10%,
physically abusive behaviours (three studies) from 7.8% to
9.8% and socially inappropriate behaviour (three studies)
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Figure 1. Search and selection procedure of the articles.
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from 16% to 25.2%. Two studies reported verbally abusive
behaviour with a prevalence rate from 13% to 17.2%. One
study reported that 15% was verbally or physically abusive at
least once during the observation week. Borderline depres-
sion, borderline anxiety, bipolar disease and schizophrenia
(each one study) were found in 13.9%, 11.1%, 2.2% and
6.2% of the patients, respectively. One study described NPS
overall as challenging behaviour in 35% of the patients
(Table 4).
Psychotropic drug use
Only two studies reported prevalence rates of PDU. The
prevalence of minor tranquillizers/anxiolytics was 12% in
one study and 23% in the other study. The frequency of
antidepressants was 26% and 34%, and major tranquillizers/
antipsychotics 19% and 36%. Anticonvulsants were studied in
one study and the prevalence was 35% (Table 4).
Methodological quality
The sample size varied between studies. Two studies were
exceptionally large and included the whole population of
interest (21,24). Other strengths of the reviewed studies are
a clearly defined target population, characteristics of the
respondents, standardized data collection methods, and the
reporting of statistical estimates. Furthermore, one study used
a validated reliable instrument which was administered by
trained persons (26). These strengths were rated with one
point according to the Guidelines for evaluating prevalence
studies (Table 2). The study using the self-developed ques-
tionnaires described above achieved a 100% response rate in
which responses were obtained from all 75 nursing homes and
all 203 questionnaires were returned (22). There are also
limitations. The sample size was low in four studies which
could have led to overestimation of the prevalence rates and
compromises generalizability (22,23,25,26).
All four studies, using the MDS, used no validated
instruments to assess NPS and solely relied on data from
the MDS (21,23–25). This is a limitation because the MDS
is not a research data set and will, according to Belanger
et al., likely have more noise in the data compared to
controlled studies (25). Also, the MDS was completed by
nursing home staff and there was no guarantee that written
guidelines were followed. Furthermore, the reliability and
validity of the TBI diagnosis from the MDS had not been
established at the time of one of these studies (23). One of
these four studies reviewed the identification of TBI among
nursing home residents using the common definition (TBI
check box item in the MDS) and the expanded definition
(check box item and ICD-9-CM codes) (24). Much more
patients were identified as having TBI with the expanded
definition compared to the common definition and, as con-
sequence, the prevalence rates of NPS were lower in this
group of patients with TBI. By using the common defini-
tion, patients who actually have TBI are not identified by
the MDS. This leads to underreporting of TBI and probably
causing an overestimation of the prevalence rates of NPS.
Also, the sizes of the validity coefficients were modest, and
depression and problem behaviour were less well affirmed
than cognition, activities of daily living and time use (29).
Although behavioural symptoms were recorded in the MDS,
none of these four studies described how these behavioural
symptoms were diagnosed and by whom. Because of this,
0.5 points were allocated to the validity and reliability cri-
teria. In two of these studies, the question about reliability
could not be answered.
Reliance on questionnaire responses by nursing home staff
was the limitation in the study of McMillan et al. (22).
According to the same study, ‘challenging behaviour’ was
defined as behaviour that staff found difficult to manage and
adversely affected the comfort of other residents. The effects of
NPS on the patient himself/herself were not taken into account.
It is possible that certain behaviour might not have been
perceived as a problem, which could have led to underreport-
ing. Although it was reported that behaviour modification
supervised by a clinical psychologist was used in only two
cases, it remains unclear how behavioural problems were diag-
nosed and by whom. We allocated 0.5 points in both the
validity and reliability criterion.
Table 3. Characteristics of the studies.
Reference Country Study Design Setting N
Age
(SD/Range) Type of ABI Instruments
Buchanan et al., 2003 (21) USA Cross-sectional Nursing
Home
12300 53.1 (21.2) Traumatic Brain Injury Minimum Data Set
McMillan et al., 2004 (22) Scotland Cross-sectional Nursing
Home
92 50 (10) Traumatic Brain Injury
Stroke
Alcohol Related
Other Brain Injury
Questionnaire
Medication Cardex
Gabella et al., 2007 (23) USA Cross-sectional Nursing
Home
239* 53 (18–99) † Traumatic Brain Injury Minimum Data Set
Karon et al., 2007 (24) USA Cross-sectional Nursing
Home
3912‡
26472§
54.3
64.6
Traumatic Brain Injury Minimum Data Set
Belanger et al., 2008 (25) USA Cross-sectional Nursing
Home
537‖ 61.56 (14.85) Traumatic Brain Injury Minimum Data Set
Wolf-Ostermann et al., 2014 (26) Germany Longitudinal RLF/SLA 40 46.2 (12.1) Traumatic Brain Injury
Subarachnoidal Haemorrhage
Inflammation/Toxic
Stroke
Other Brain Injury
Hospital Anxiety
Depression Scale
SD = Standard Deviation. NPS = Neuropsychiatric Symptoms. RLF = Residential Living Facility. SLA = Supported Living Accommodations. USA = United States of
America. * = Population of patients with only TBI. † = Median. ‡ = Common Definition. § = Expanded Definition. ‖ = TBI Nonwanderers.
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One study used the HADS (26). The HADS has been
shown to be an effective measure of emotional distress, but
is unable to consistently differentiate between the con-
structs of anxiety and depression, which means that its
use needs to be targeted to a more general measurement
of distress (30). This was confirmed by a later study (31).
Misclassification between anxiety and depression might
have occurred. Therefore, we allocated 0.5 points to the
validity criterion.
After calculating the total score for each study, all studies
had a score greater than six and were considered as having
good quality. The lowest score was 6.5 and the highest score
was 7.5 out of 8. The individual ratings and total scores are
found in Table 2.
Remarkably, one study did not register the indication for
PDU and in another study the indication was not clear
(21,22). It remains unclear how many patients actually
received psychotropic drugs because of NPS.
Discussion
To the best of our knowledge, this is the first review that
systematically assessed the prevalence of NPS and PDU in
patients below 65 years of age with ABI in long-term care
settings. Six studies were found and all studies were of good
methodological quality. The place of residence was mainly a
nursing home and most studies were conducted in patients
with TBI. Depressive symptoms were the most common NPS.
Only two studies were published about PDU, in which tran-
quillizers were the most prevalent psychotropic drugs fol-
lowed by anticonvulsants and antidepressants.
Comparison with other populations
ABI has also been studied in older patients living in LTCFs,
mainly those with TBI and stroke (32–34). They appeared to
have higher prevalence rates of aggression and depression
than younger patients. Compared to younger patients with
similar TBI severity, elderly patients showed worse physical
and cognitive outcomes and they were also more often dis-
charged to LTCFs (35). A study performed in geriatric
patients with stroke found that 1 year after admission,
patients who were still in a LTCF showed significantly more
agitation and depression than those who had been discharged
(36). The worse outcome and the higher frequency of LTCF
admissions may contribute to the higher prevalence rates of
aggression and depression in LTCFs in elderly patients with
ABI. The prevalence of anxiety in these older populations was,
however, lower in TBI and higher in stroke (32,33). A recent
study of young, middle-aged and older adults with TBI living
in the community found that older adults (60–64 years)
experienced less anxiety than young (20–24 years) and mid-
dle-aged (40–44 years) adults (37). A possible explanation for
this is the inability to maintain established roles in society,
such as employment and providing for a family, due to TBI-
related disabilities in the younger adults (38,39). For stroke,
no comparisons could be made.
In settings other than LTCFs, ABI has been studied as well.
The psychosocial and emotional outcomes were studied in a
community-based follow-up study of 53 patients with mild to
very severe TBI sustained 10 years previously (40). The pre-
valence rates of clinically significant anxiety and depression
were 33% and 42% in patients with severe injuries and 22%
and 35%, respectively, in patients with very severe injuries.
Aggression scores were significant in 12% of the patients. The
reported prevalence rates of anxiety in this study are higher in
contrast to the reviewed studies. The prevalence rates of
depression are similar in comparison with the study of
Gabella et al. (23). Aggression is more prevalent in three of
the reviewed studies (21,23,24).
The occurrence of aggressive behaviour was established in
a group of 89 patients with closed head injury admitted to the
University of Iowa Hospitals and Clinics (n = 58) and the
Iowa Methodist Medical Center (n = 31) (41). Aggressive
behaviour was found in 33.7% of patients with TBI during
the first 6 months after injury and was significantly associated
with the presence of major depression. A mood or anxiety
disorder was found in 26.4% and 12.6% of the patients,
Table 4. Neuropsychiatric symptoms and psychotropic drug use.
Reference Behaviour/NPS N
Psychotropic
Use N
Buchanan et al.
(21).
Depression
Physically Abuse
Others
Verbally Abuse Others
Socially Inappropriate
Behaviour
21%
9%
13%
16%
Antidepressant
Antipsychotic
Anxiolytic
26%
19%
12%
McMillan et al.
(22).
Challenging
Behaviour
Physically Violent
32
9
Major
Tranquillizer
Anticonvulsant
Antidepressant
Minor
Tranquillizer
33
(36%)
*
36
(35%)
*
31
(34%)
*
21
(23%)
*
Gabella et al. (23). Depression
Anxiety
Abusive Behaviour
Inappropriate
Behaviour
39.3%
10%
15%
18%
Karon et al. (24). Verbally Abusive‡
Physically Abusive
Socially Inappropriate
Verbally Abusive§
Physically Abusive
Socially Inappropriate
17.2%
9.8%
25.2%
13.9%
7.8%
19.8%
Belanger et al.
(25).
Anxiety Disorder
Depression
Bipolar Disease
Schizophrenia
47
(8.75%)
152
(28.31%)
12
(2.23%)
33
(6.15%)
Wolf-Ostermann
et al. (26).
Borderline Anxiety
Anxiety
Borderline Depression
Depression
4/36
(11.1%)
1/36
(2.8%)
5/36
(13.9%)
5/36
(13.9%)
NPS = Neuropsychiatric Symptoms. * = Some patients received more than one
medication of this type. ‡ = Common Definition. § = Expanded Definition.
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respectively. The studies in our review found lower prevalence
rates for aggression and anxiety. With regard to depression,
two reviewed studies found a higher prevalence and two
studies a lower prevalence.
The prevalence of aggression has been studied among 57
inpatients with ABI at a specialized post-acute treatment
centre in a large general psychiatric hospital in the
Netherlands (42). During a period of 17 weeks, 42% of the
patients had engaged in aggressive behaviour on one of more
occasions, which is much higher than the prevalence rates
described in our review.
There are also differences in PDU. Anticonvulsants were
the most prescribed type of medication in patients with TBI
below 65 years in a retrospective cohort study (n = 306) (43).
In patients over 65 years, the prevalence of anticonvulsants
was lower. Older patients with stroke also used less antic-
onvulsants (44). In a sample of 520 patients with TBI, 59
patients had post-traumatic seizures and most seizures
occurred in patients between 20 and 50 years of age. The
prevalence of antidepressants was higher in older patients
with TBI (43). Other studies also found more use of antide-
pressants in older patients with TBI and stroke (32,44). This
can probably be explained by higher prevalence rates of
depression in older patients with TBI and stroke (32–34).
The use of anxiolytics (20%) in TBI was also different. One
study found a higher prevalence rate (20%) and second study
a lower prevalence rate (5.9%) (32,43). However, the use of
anxiolytics was highest in the age group 45–54 years (43). The
reason for this might be the above-described anxiety caused
by the inability to maintain established roles in society
(38,39). More antipsychotics (41.5%) appear to be prescribed
in older patients with TBI and less (8%) in older patients with
stroke (32,33).
Remarkable findings
A remarkable finding is that the TBI studies in our review,
which reported depression and anxiety, did not report how
many patients with anxiety also had depression. Anxiety was
found to be highly co-morbid with depression in a study of
young, middle-aged and older adults with TBI (37). In their
review, Lecrubier concludes that depression and anxiety are
often co-morbid which causes greater disability and imposes a
greater burden on the patients’ daily lives and on healthcare
services (45). They recommend that co-morbid anxiety and
depression should not be viewed in isolation despite the fact
that anxiety and depression are often experienced, diagnosed
and treated as independent conditions (37,46).
Furthermore, we noted that anoxia as cause of ABI was not
reported. Two studies, however, reported ‘other brain injury’
which could include anoxia but this is not clear (22,26).
Anoxia as a cause of severe ABI has been increasingly found
in VS/UWS and has become the major cause after cardiopul-
monary resuscitation (47–49). However, little is known about
the neuropsychiatry, such as memory impairment and apathy,
of ABI caused by hypoxia/anoxia (50,51). If they regain con-
sciousness, these patients may experience severe conse-
quences, such as NPS, which have a high impact on their
lives and their environment.
Regarding PDU, the Scottish study stated that a large
number of patients had anticonvulsants without the diagnosis
of epilepsy, which may be partially explained by continuation
as a prophylactic or because of prescription for other reasons,
such as reduction in aggression (22). Another indication for
anticonvulsants is neuropathic pain and antidepressants are
also used for this indication (52). Furthermore, nursing home
records did not describe the indication for medication use,
but prescription of major or minor tranquillizers tended to be
more common in patients with challenging behaviour. The
other study which reported prevalence rates of PDU did not
register the indication for PDU (21). It remains unclear how
many patients actually received psychotropic drugs because
of NPS.
Also, medication was not reviewed in 78.8% of the patients
with major tranquillizers, 70% with antidepressants, 57.1%
with minor tranquillizers, and 72.4% with anticonvulsants
(22). Patients with challenging behaviour tended to have had
their medication reviewed, but concrete numbers were not
reported. It also remains unclear in how many cases psycho-
tropic drugs were discontinued because of the absence of NPS
at the time of the medication review. The rate of reappearance
of NPS after discontinuation of PDU is not clear as well.
Therefore, it is impossible to determine whether NPS had
existed without medication or not. It is important to note
that in some cases continuation of medication might have
been inappropriate if a valid indication was absent. A review
concluded that all medication for co-morbid diseases should
be critically evaluated and medication that does not benefit
the patient in any way should be stopped (53).
Limitations of this review
Concerning this review, there are limitations to acknowl-
edge. We did a combined search of specific headings and
keywords in four different databases, but some studies
might have been missed, written in a language other than
English, Dutch or German. Another limitation is the use of
a mean/median age instead of restricting to a population
only consisting of people up to 65 years of age. In the latter
case, only three studies could have been included. Although
the mean/median age indicates that the number of patients
below 65 is larger than the number of older patients,
inclusion of the three studies that also included some peo-
ple above 65 would have resulted in reporting slightly
higher rates of depression, aggression and the use of anti-
depressants, and lower rates for anticonvulsants.
Considerations and implications
Despite the fact that the reported studies are of good quality,
it is difficult to draw conclusions from the reported preva-
lence rates and they have to be interpreted with caution.
Reasons for this are the different populations, the use of
different instruments, the varying sample sizes and the limita-
tions of the included studies, such as a low sample size, and
not using validated instruments to assess NPS.
One study was conducted in Veterans Health
Administration nursing homes (25). These nursing homes
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have a special population and residents are predominantly
men contrary to the population of community nursing
homes. The findings in this study are not generalizable to a
population of patients with ABI other than veterans.
NPS in LTCFs are prevalent and have a high impact on
patients with ABI and their surroundings, in the first place
family but also other patients and nursing home staff in
LTCFs. A recent review found that challenging behaviour
hindered the provision of quality care and required the imple-
mentation of proactive nursing strategies to maintain safety
for both patients with TBI and nurses (54). Nurses had to
watch for, and identify, triggers for aggression in patients with
TBI and they expressed being fearful for their personal safety.
That review also stated that to provide effective care for
patients with TBI exhibiting challenging behaviour such as
aggression, nurses needed to understand their own percep-
tions of challenging behaviour and how these perceptions
might impact their care choices. Appropriate skills, through
a training programme, would better enable nurses to deliver
more effective care and avert crisis situations (55). Knowledge
about the patient’s disease awareness is important to ade-
quately manage consequences of ABI (56). Factors which
contribute to a patient’s limited disease awareness are an
increased psychological defence mechanism due to more
changes in life after ABI, having more cognitive disorders
and not being informed sufficiently.
Pharmacological treatment may have adverse effects.
Antipsychotics, for example, which are used for the treatment
of psychoses, agitation and aggression, may have adverse
effects on cognition as a study found improvement in cogni-
tion after discontinuation of antipsychotics in patients with
TBI (57). In long-term therapy, antipsychotics have severe
side effects such as stroke and increased mortality (58). A
review about cognitive behavioural therapy (CBT), a non-
pharmacological anger self-management technique, con-
cluded that CBT appears to be an effective tool to control
aggression in a population with ABI (59). The results of that
review show promise for CBT as a non-pharmacological, safe,
psychotherapy alternative to medication use for treatment of
aggression after brain injury. However, their conclusion is
that further research with long follow-up times is needed
and the effects of CBT in acute and chronic populations
with ABI need to be assessed.
Recommendations
Some recommendations for future studies can be made. We
propose to assess a wide range of NPS, such as aggression,
with the use of a limited number of reliable, validated, stan-
dardized instruments. It is advised to report possible co-mor-
bid anxiety and depression. Regarding medication, we
recommend to register the indication for PDU so that it is
clear whether psychotropics are used for the treatment of NPS
or for another indication such as neuropathic pain (52).
Barriers or challenges for performing research in LTCFs
and how to bridge the gap between knowledge and practice
have been described (60). For example, non-pharmacological
studies are more complicated to conduct in nursing homes
than pharmacological studies. Other challenges are number
and severity of co-morbidities, and the internal organization
of nursing homes, such as the presence of special care units.
With regard to research ethics, cognitive impairment may be a
problem because signed informed consents are impossible to
obtain from some patients.
In the Netherlands, we are in the process of bridging this
gap. Dutch patients with all type of ABI who are unable to live
at home independently live on special ABI wards in LTCFs
(61). The benefit of concentrating all types of patients with
ABI on specialized wards is obtaining clinical experience in
treating a broad range of consequences. The provision of care
is facilitated through the use of general care standards that
have been developed in the Netherlands for adults and youth
(0–24 years) with TBI, to guide the treatment of consequences
such as NPS (62,63). The care standard for adults contains a
development agenda with four research questions (62). One of
these questions is about which care is effective in long-term
care and prevents the appearance or deterioration of problems
in daily life. With this, expertise in NPS can be developed and
training of healthcare professionals can be facilitated. In addi-
tion, in 2016 an ABI network of expertise, in which LTCFs are
participating with researchers, has been established for speci-
fic subcategories of ABI, such as disorders of consciousness
and patients with consciousness who experience long-term
consequences (64). Also, The Netherlands have developed a
roadmap towards academic medicine in long-term care (65).
Key elements are a significant contribution in the medical
curriculum, a specialty with a 3-year specialist training pro-
gramme, and academic networks that provide an infrastruc-
ture for teaching, research and best practices. Furthermore,
the prevalence of specific subcategories of ABI, VS/UWS and
the Locked-in Syndrome (LIS), in LTCFs has been studied
(47,48,66). The circumstances in the Netherlands provide a
good opportunity to conduct this kind of prevalence studies,
regarding the high responses between 91% and 100%.
Conclusions
There is a knowledge gap concerning NPS and PDU in
patients below 65 years of age in the chronic phase of ABI
in LTCFs. These patients experience lifelong consequences,
such as NPS, regardless the cause of ABI that have a high
impact on them and their environment. Metaphorically, it is
mainly a black box. Although there is increasing attention for
the survival of patients with severe ABI, it is also necessary to
have eyes for (severe) long-term consequences of ABI in a
vulnerable group of patients. This review is a first step
towards optimal provision of care for these patients.
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